Thus, in HCC cells, FATP5 loss may increase both glycolysis and the energy metabolism pathway, leading to inhibition of AMPK and activation of mTOR, thereby accelerating HCC cell migration and invasion both in vitro and in vivo. This evidence concerns the gene SLC27A5 and hepatocellular carcinoma.